Activation of phenacetin O-deethylase activity by α-naphthoflavone in human liver microsomes

References

• BALDWIN, S. J., BLOOMER, J. C., SMITH, G. J., AYRTON, A. D., CLARKE, S. E. and CHENERY, R. J., 1995, Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9. Xenobiotica, 25, 261–270.
   PubMed Web of Science ®Google Scholar
• Booms, A. R., KAHN, G. C., WHYTE, C., BRODIE, M. J. and DAVIS, D. S., 1981, Biphasic 0-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractions. Biochemical Pharmacology, 30, 2451–2456.
   PubMed Web of Science ®Google Scholar
• BOURRIr, M., MEUNIER, V., BERGER, Y. and FABRE, G., 1996, Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. journal of Pharmacology and Experimental Therapeutics, 277, 321–332.
   PubMed Web of Science ®Google Scholar
• BUTLER, M. A., GUENGERICH, F. P. and KADLUBAR, F. F., 1989, Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4--methyl-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases. Cancer Research, 49, 25–31.
   PubMed Web of Science ®Google Scholar
• CoNNEY, A. H., PANTUCK, E. J., HSIAO, K.-C., GARLAND, W. A., ANDERSON K. E., ALVARFS, A. P. and KAPPAS, A., 1976, Enhanced phenacetin metabolism in human subjects fed charcoal-broiled beef. Clinical Pharmacology and Therapeutics, 20, 633–642.
   Google Scholar
• GORSKI, J. C., Jos, D. R., WRIGITTON, S. A. and HALL, S. D., 1997, Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone. Xenobiotica, 27, 243–256.
   PubMed Web of Science ®Google Scholar
• HUG, M. T., JOHNSON, E. F., MULLER -EBERHARD U., KOOP, D. R., COON, M. J. and CONNEY, A. H., 1981, Specificity in the activation and inhibition by flavonoids of benzo[a]pyrene hydroxylation by cytochrome P-450 isozymes from rabbit liver microsomes. journal of Biological Chemistry, 256, 10897–10901.
   Google Scholar
• JOHANNESEN, K. A. M. and DEPIERRE, J. W., 1978, Measurement of cytochrome P-450 in the presence of large amounts of contaminating hemoglobin and methemoglobin. Analytical Biochemistry, 86, 725–732.
   Google Scholar
• KAHN, G. C., Booms, A. R., BRODIE, M. J., TOVERUD, E.-L., MURRAY, S. and DAVIS, D. S., 1985, Phenacetin 0-deethylase: an activity of a cytochrome P-450 showing genetic linkage with that catalysing the 4-hydroxylation of debrisoquine ? British Journal of Clinical Pharmacology, 20, 67–76.
   Google Scholar
• KAMATAKI, T. and KITAGAWA, H., 1974, Effects of lyophilization and storage of rat liver microsomes on activity of aniline hydroxylase, contents of cytochrome b and cytochrome P-450 and aniline-induced P-450 difference spectrum. Japanese Journal of Pharmacology, 24, 195–203.
   PubMedGoogle Scholar
• KOBAYASHI, K., NAKAJIMA, M., CHIBA, K., YAMAMOTO, T., TANI, M., ISHIZAKI, T. and KUROIWA, Y., 1998, Inhibitory effects of antiarrhythmic drugs on phenacetin 0-deethylation catalysed by human CYP1A2. British Journal of Clinical Pharmacology, 45, 316–368.
   Web of Science ®Google Scholar
• KOBAYASHI, K., NAKAJIMA, M., OSHEVIA, K., SHIMADA, N., YoKoi, T. and CHIBA, K. Involvement of CYP2E1 as a low-affinity enzyme in phenacetin 0-deethylation in human liver microsomes. Drug Metabolism and Disposition, in press.
   Google Scholar
• KOLEY, A. P., BUTERS, J. T. M., ROBINSON, R. C., MARKOWITZ, A. and FRIEDMAN, F. K., 1997, Differential mechanism of cytochrome P450 inhibition and activation by a-naphthoflavone. Journal of Biological Chemistry, 272, 3149–3152.
   Google Scholar
• LOWRY, 0. H., ROSEBROUGH, N. J., FAR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   Google Scholar
• McMANus, M. E., BURGESS, W. M., VERONESE, M. E., HUGGETT, A., QUATTROCHI, L. C. and TUKEY R. H., 1990, Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food derived heterocyclic amine mutagens by human cytochrome P450. Cancer Research, 50, 3367–3376.
   Google Scholar
• MUCK, W., 1994, Pharmacokinetic drug interaction. In J. Kuhlmann (ed.), Drug Interactions Studies During Drug Development (Munich; W. Zuckschwerdt), pp. 50–54.
   Google Scholar
• NAKAJIMA, M., YoKoi, T., MIZUTANI, M., SHIN, S., KADLUBAR, F. F. and KAMATAKI, T., 1994, Phenotyping of CYP1A2 in Japanese population analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene. Cancer Epidemiology, Biomarkers & Prevention, 3, 413–421.
   PubMed Web of Science ®Google Scholar
• NELSON, D. R., KOYMANS, L., KAMATAKI, T., STEGEMAN, J. J., FEYEREISEN, R., WAKVIAN, D. J., WATERMAN, M. R., GOTOH, 0., COON, M. J., ESTABROOK, R. W., GUNSALUS, I. C. and NEBERT D. W., 1996, P450 superfamily; update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1–42.
   Google Scholar
• NEWTON, D. J., WANG, R. W. and Lu, A. Y. H., 1995, Cytochrome P450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metabolism and Disposition, 23, 154–158.
   PubMed Web of Science ®Google Scholar
• ONO, S., HATANAKA, T., HOTTA, H., SATOH, T., GONZALEZ, F. J. and TSUTSUI, M., 1996, Specificity of substrate and inhibitor probes for cytochrome P45 Os: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica, 26, 681–693.
   PubMed Web of Science ®Google Scholar
• PANTUCK, E. J., HSIAO, K.-C., MAGGIO, A., NAKAIVIURA, K., KUNTZIVIAN, R. and CoNNEY, A. H., 1974, Effect of cigarette smoking on phenacetin metabolism. Clinical Pharmacology and Therapeutics, 15, 9–17.
   Google Scholar
• PANTUCK, E. J., PANTUCK, C. B., GARLAND, W. A., MIN, B. H., w
   Google Scholar
• ATTENBERG, L. W., ANDERSON, K. E., KAPPAS, A. and CONNEY, A. H., 1979, Stimulatory effect of brussels sprouts and cabbage on human drug metabolism. Clinical Pharmacology and Therapeutics, 25, 88–95.
   PubMed Web of Science ®Google Scholar
• PASTRAKULJIC, A., TANG, B. K., ROBERTS, E. A. and KALO W., 1997, Distinction of CYP1A1 and CYP1A2 activity by selective inhibition using fluvoxamine and isosafrole. Biochemical Phar-macology, 53, 531–538.
   PubMed Web of Science ®Google Scholar
• RENDIC, S. and Di CARLO, F. J., 1997, Human cytochrome P450 enzymes; a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metabolism Reviews, 29, 413-580. RODRIGUES, A. D., 1994, Use of in vitro human metabolism studies in drug development. An industrial perspective. Biochemical Pharmacology, 48, 2147–2156.
   Google Scholar
• SCHWAB, G. E., RAUCY, J. L. and JOHNSON, E. F., 1988, Modulation of rabbit and human hepatic cytochrome P-450 catalyzed steroid hydroxylations by a-naphthoflavone. Molecular Pharma-cology, 33, 493–499.
   PubMed Web of Science ®Google Scholar
• SHEVIADA, T., YAIVIAZAKI, H., MIMURA, M., INUI, Y. and GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogenes and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414–423.
   PubMed Web of Science ®Google Scholar
• SHOU, M., GROGAN, J., MANCEWICZ, J. A., KRAUSZ, W., GONZALEZ, F. J., GELBOIN, H. V. and KORZEWKA, K. R., 1994, Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site. Biochemistry, 33, 6450–6455.
   PubMed Web of Science ®Google Scholar
• SPATZENEGGER, M. and JAEGER, W., 1995, Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metabolism Reviews 27, 397–417.
   PubMed Web of Science ®Google Scholar
• TASSANEEYAKUL, W., BIRKETT, D. J., VERONESE, M. E., McMANus, M. E., TUKEY, R. H., QUATTROCHI L. C., GELBOINT, H. V. and MINERS, J. 0., 1993a, Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.1ournal of Pharmacology and Experimental Therapeutics, 265, 401–407.
   Google Scholar
• TASSANEEYAKUL, W., VERONESE, M. E., BIRKETT, D. J., GONZALEZ, F. J. and MINERS, J. 0., 1993b, Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Biochemical Pharmacology, 46, 1975–1981.
   Google Scholar
• UENG, Y.-F., SHEVIADA, T., YAIVIAZAKI, H. and GUENGERICH, F. P., 1995, Oxidation of afiatoxin B1 by bacterial recombinant human cytochrome P450 enzymes. Chemical Research in Toxicology, 8, 218–225.
   PubMed Web of Science ®Google Scholar
• UENG, Y.-F., KUWABARA, T., CHUN, Y.-J. and GUENGERICH, F. P., 1997, Cooperativity in oxidations catalyzed by cytochrome P450 3A4. Biochemistry, 36, 370–380.
   PubMed Web of Science ®Google Scholar
• WRIGHTON, S. A., CAMPANILE, C., THOMAS, P. E., MAINES, S. L., WATKINS, P. B., PARKER, G., MENDEZ - PICON, G., HANIU, M., SHIVELY, J. E., LEVIN, W. and GUZELIAN, P. S., 1986, Identification of a human liver cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the rat. Molecular Pharmacology, 29, 405–410.
   Google Scholar
• YAIVIAZAKI, H., JoHNsoN, W. W., UENG, Y. F., SHIIVIADA, T. and GUENGERICH, F. P., 1996a, Lack of electron transfer from cytochrome b in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4/NADPH-cytochrome P450 reductase system and studies with apo-cytochrome bs. Journal of Biological Chemistry, 271, 27438–27444.
   PubMed Web of Science ®Google Scholar
• YAIVIAZAKI, H., NAKANO, M., GILLAM, E. M. J., BELL, L. C., GUENGERICH, F. P. and SHIIVIADA, 1996b, Requirements for cytochrome b in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P4502E1 and by human liver microsomes. Biochemical Pharmacology, 52, 301–309.
   Google Scholar
• YAIVIAZAKI, H., NAKANO, M., IIVIAI, Y., UENG, Y. F., GUENGERICH, F. P. and SHEVIADA, T., 1996c, Roles of cytochrome b in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Archives of Biochemistry and Biophysics, 325, 174–182.
   PubMed Web of Science ®Google Scholar